Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
德纳维制药股票交易较高，公司报告超预期的第三季度每股收益结果，并推出20000万美元的股票回购计划。HC Wainwright & Co. 重申对该股票的买入评级。
Dynavax Technologies Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results and Launched a $200 Million Share Buyback Program. HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
德纳维制药股价上涨，该公司公布了优于预期的第三季度每股收益结果，并启动了20000万美元的股票回购计划。瑞士信贷重申该股的买入评级。
资讯热榜
更新时间